For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Ottawa, Ontario K2G6E2
0 studies enrolling now · 18 studies all time
What they study most
Alzheimer's Disease, Carcinoma of Renal Pelvis, Carcinoma of Ureter, Carcinoma of Urinary Tract, Cardiovascular Disease, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Glioblastoma, Head and Neck Cancer, Muscular Dystrophy, Duchenne, Non Small Cell Lung Cancer, Psoriasis
Studies at this site
- A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
- A Study of Tadalafil for Duchenne Muscular Dystrophy — Stopped early
- Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease — Stopped early
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
- A Study in Head and Neck Cancer — Completed
- A Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
- A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
- A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes — Completed
- Enzastaurin Versus Lomustine in Glioblastoma — Completed
- Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma — Completed
- A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
- Reduction in the Occurrence of Center-Involved Diabetic Macular Edema — Completed
- Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
- Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer — Completed
- Effect of LY2062430 on the Progression of Alzheimer's Disease — Completed
- A Study for Adults With Plaque Psoriasis — Stopped early
- Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) — Completed